Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank79
3Y CAGR-18.3%
5Y CAGR+18.3%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-18.3%/yr
vs +32.5%/yr prior
5Y CAGR
+18.3%/yr
Recent deceleration
Acceleration
-50.8pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.39 | +31.3% |
| 2024 | 3.34 | -42.3% |
| 2023 | 5.79 | -28.0% |
| 2022 | 8.04 | +272.8% |
| 2021 | 2.16 | +13.9% |
| 2020 | 1.89 | +172.7% |
| 2019 | 0.69 | -73.4% |
| 2018 | 2.61 | -20.0% |
| 2017 | 3.26 | +126.5% |
| 2016 | -12.33 | - |